Skip to main content

Table 3 Characteristics of Patients with HAF in OMH by Etiology

From: Hospital-acquired fever in oriental medical hospitals

 

Total

(n = 560)

Infection

(n = 331)

Non-infection

(n = 179)

p

Demographics

 Age (years)

61.4 ± 15.2

63.7 ± 15.3

58.0 ± 14.7

< 0.001

 Male sex

278 (49.6)

169 (51.1)

81 (45.3)

0.228

Underlying diseases

 Diabets mellitus

141 (25.2)

90 (27.2)

40 (22.3)

0.243

 Hypertension

234 (41.8)

161 (48.6)

60 (33.5)

0.001

 Cerebrovascular accident

251 (44.8)

179 (54.1)

63 (35.2)

< 0.001

 Solid cancer

246 (43.9)

109 (32.9)

100 (55.9)

< 0.001

 Metastatic cancer

205 (36.6)

88 (26.6)

85 (47.5)

< 0.001

Healthcare- associatied conditions

 Receipt of anticancer chemotherapy

113 (20.2)

40 (12.1)

56 (31.3)

< 0.001

 Central venous catheter

68 (12.1)

43 (13.0)

21 (11.7)

0.682

 Urinary catheter

111 (19.8)

79 (23.9)

27 (15.1)

0.022

 Percutaneous drainage

68 (12.1)

47 (14.2)

20 (11.2)

0.410

 Previous operation

76 (13.6)

47 (14.2)

21 (11.7)

0.434

 Previous intervention

24 (4.3)

14 (4.2)

9 (5.0)

0.678

 Previous admission

414 (74.0)

250 (75.5)

134 (74.9)

0.867

 Previous antibiotics

128 (22.9)

98 (29.6)

27 (15.1)

< 0.001

Concurrent treatment

 Herbal medicine

506 (90.4)

310 (93.7)

161 (89.9)

0.132

 Invasive Oriental medical procedure

532 (95.0)

314 (94.9)

171 (95.5)

0.739

 Acupuncture

502 (89.6)

302 (91.2)

161 (89.9)

0.630

 Cupping

97 (17.3)

56 (17.0)

35 (19.6)

0.468

 Moxibustion

417 (74.5)

242 (73.3)

138 (77.1)

0.352

SIRSa (severe or shock)

47 (8.4)

28 (8.5)

14 (7.8)

0.788

Laboratory findings at the onset of fever

 White Blood Cell(/mm3)

9550 (100–32,500)

10,400 (800–32,500)

7000 (100–24,000)

< 0.001

 Neutropenia (WBC < 1000/mm3)

5 (0.9)

3 (1.0)

2 (1.3)

0.662

 C-reactive protein

5.3 (0.0–39.7)

5.4 (0.0–39.7)

4.2 (0.0–22.5)

0.767

Fever pattern

 Peak body temperature (°C)

38.5 ± 0.6

38.6 ± 0.6

38.4 ± 0.6

0.151

 Duration of fever

1.0 (0.0–18.0)

1.0 (0.0–18.0)

1.0 (0.0–17.0)

0.263

 No defervescence

43 (7.7)

23 (6.9)

12 (6.7)

0.917

  1. aSIRS systemic inflammatory response syndrome